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Dear Editor,
We read with interest the article ‘A patient with abdominal 
pain and a rash’ by van Laarhoven et al.1 They made the 
diagnosis of Henoch-Schönlein purpura (HSP) in their 
patient using the American College of Rheumatology 
(ACR) criteria.2 Recently, however, the diagnostic criteria 
of HSP were modified by EULAR/PReS (the European 
League against Rheumatism/ Paediatric Rheumatology 
European Society)3 to overcome the weak points of the 
ACR criteria. In these new criteria, the age criterion was 
deleted, ‘predominant IgA deposition’ was included in the 
definition of the criterion describing ‘biopsy’, and arthritis 
and renal involvement were added to the group of criteria. 
Nevertheless, there are some problems in the correct 
diagnosis of HSP.3
Firstly, the ACR or EULAR/PReS criteria cannot detect 
the atypical presentation (e.g. delayed appearance of 
purpura) of HSP,4 leading to unnecessary procedures, 
such as appendectomy, or unfavorable outcome, such as 
death. Therefore, Kaneko et al. reported that measurement 
of plasma factor XIII (fibrin stabilising factor) might 
be useful for the early diagnosis of HSP, because it is 
decreased even without the purpuric rash, although not a 
diagnostic criterion of HSP.5
Secondly, skin biopsy cannot exactly differentiate HSP 
from hypersensitivity vasculitis, because IgA deposits may 
not be stained according to the biopsy site or various factors 
(e.g. phagocytosis with time) even in HSP.6 
Thirdly, polyangiitis overlap syndrome can be missed 
even though a patient presenting with the features 
of HSP shows IgA deposits on biopsy specimens.7 
Therefore, if a patient has an atypical presentation or 
a progressive course, the overlap of other vasculitis 
l E T T E r  T o  T H E  E d i T o r
Current problems in the diagnosis of 
Henoch-schönlein purpura according to the 
ACr or EUlAr/Pres criteria
should also be examined to prevent unexpected fatal 
situations. 
In the future, further studies should be performed to 
elucidate the epidemiology and natural course of HSP 
based on the new EULAR/PReS criteria as well as the 
usefulness of the criteria.
J.i. shin, J. seung lee*
Department of Paediatrics, The Institute of Kidney 
Disease, Yonsei University College of Medicine, Severance 
Children’s Hospital, Seoul, Korea, *corresponding author: 
tel.: +82-2-2228 20 54, fax: +82-2-393 91 18, e-mail: 
jsyonse@yumc.yonsei.ac.kr
r E f E r E N C E s
Van Laarhoven HW, Blokx WA, Seyger MM, Koopmans PP. A patient with 1. 
abdominal pain and a rash. Neth J Med 2008;66:48-9.
Mills JA, Michel BA, Bloch DA, et al. The American College of 2. 
Rheumatology 1990 criteria for the classification of Henoch-Schönlein 
purpura. Arthritis Rheum 1990;33:1114-21.
Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus 3. 
criteria for the classification of childhood vasculitides. Ann Rheum Dis 
2006;65:936-41.
Uza N, Yazumi S, Tanabe K, et al. Henoch-Schönlein purpura in an elderly 4. 
patient with unusual manifestation. Endoscopy 2007;39:E35-6. 
Kaneko K, Fujii S, Shono T, Matsumoto Y, Arii N, Kaneko K. Diagnostic 5. 
value of plasma factor XIII in Henoch-Schönlein purpura. Pediatr Nephrol 
2004;19:702-3.
Davin JC, Weening JJ. Diagnosis of Henoch-Schönlein purpura: renal or 6. 
skin biopsy? Pediatr Nephrol 2003;18:1201-3.
Watanabe K, Abe H, Mishima T, Ogura G, Suzuki T. Polyangitis overlap 7. 
syndrome: a fatal case combined with adult Henoch-Schönlein purpura 
and polyarteritis nodosa. Pathol Int 2003;53:569-73.
© 2008 Van Zuiden Communications B.V. All rights reserved.
